Skip to main content
Hubert Chen, MD, Endocrinology, Dallas, TX

HubertChih-HsinChenMD

Endocrinology • Dallas, TX

President & Chief Scientific Officer, Forte Biosciences Affiliated Faculty, UCSD

Join to view full profile

Dr. Chen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Chen's full profile

Already have an account?

Summary

  • •    C-level officer in the biotech/pharmaceutical industry, with 12 years of executive track record in both public and private companies and pivotal roles in initial/follow-on public offerings.
    •    Research & development experience across multiple therapeutic areas, with 10 additional years of basic research and teaching record in academia.
    •    Skilled in communicating with diverse audiences, including scientific and medical communities, board members, investors and analysts.
    •    Successfully designed and executed the clinical, nonclinical, and regulatory strategy for Bonsity® (PF708), a teriparatide injectable for the treatment of high-risk osteoporosis, leading to NDA approval in 2019.
    •    Experienced in negotiating with multiple regulatory agencies (US FDA, EMA, Japan’s PMDA, Health Canada), with a passion for translating scientific breakthroughs and proposing accelerated development programs.

Education & Training

  • Gladstone Institute of Cardiovascular Disease
    Gladstone Institute of Cardiovascular DiseasePost-Doctoral Fellowship, Cardiovascular Disease, 1999 - 2002
  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 1998 - 2002
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1995 - 1998
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1995

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1998 - 2026

Awards, Honors, & Recognition

  • Professor of the Year Master of Science Program in Drug Development & Product Management, UCSD, 2019, 2021

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Metacrine Appoints Hubert Chen, M.D. As Chief Medical Officer and Andrew Guggenhime to the Board of Directors
    Metacrine Appoints Hubert Chen, M.D. As Chief Medical Officer and Andrew Guggenhime to the Board of DirectorsSeptember 6th, 2018

Grant Support

  • Increased Leptin Sensitivity In DGAT -/- MiceNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2003

Dr. Hubert Chen, Dr. Hubert Chen, MD, Dr. H Chen, Dr. Hubert Chih-Hsin Chen